Acupuncture and Trigeminal Neuralgia Study

By Aneeta Prem MBE

People living with trigeminal neuralgia hear about “new” options long before the evidence settles. That can feel hopeful. However, it can also be risky. For that reason, this post explains the acupuncture and trigeminal neuralgia study in plain English, without hype.

Acupuncture and Trigeminal Neuralgia Study: What was tested

The study tested electroacupuncture for trigeminal neuralgia. Electroacupuncture uses gentle electrical pulses through acupuncture needles.

Researchers compared three approaches:

electroacupuncture vs sham (placebo-style) electroacupuncture
low-dose carbamazepine vs placebo
a combination of electroacupuncture plus low-dose carbamazepine vs controls

The trial used a 2×2 “factorial” design and included 120 adults. Researchers tracked pain scores and follow-up outcomes over several months.

Acupuncture and trigeminal neuralgia study: what the results showed

The authors reported that:

Electroacupuncture alone reduced pain scores more than sham electroacupuncture
carbamazepine alone reduced pain scores more than placebo
The combination appeared to produce the largest reduction in pain scores

They also reported fewer treatment-related adverse events in the electroacupuncture group than in the carbamazepine group during the study period.

That is a meaningful signal. Even so, it is not the same as a final answer.

Why this study matters, and why caution still matters

This acupuncture and trigeminal neuralgia study matters because it uses a randomised design and follows patients beyond the first few weeks. That makes it stronger than many headlines.

Even so, several fair questions remain.

First, the study tested a defined protocol delivered under trial conditions. In real life, services vary widely. Secondly, trigeminal neuralgia is not one simple condition. Some people have classic TN. Others have mixed facial pain or complex histories. Because of that, results do not always transfer neatly into everyday care.

Finally, pain scores matter. However, people also need to know what happens to function, triggers, sleep, work, and quality of life over time.

Where this sits in UK care

In the UK, treatment often starts with medication. The NHS explains that carbamazepine is the only medicine licensed to treat trigeminal neuralgia in the UK. Clinicians usually start with a low dose and increase carefully.

When medication fails, side effects become too difficult, or symptoms change, specialist teams may discuss procedures or surgery. The Royal College of Surgeons guidance sets out pathways and stresses the importance of correct diagnosis and specialist management.

So, this study does not replace established routes of care. Instead, it adds evidence that may support informed conversations, especially when people ask about acupuncture in a clinical context.

Questions to ask before trying electroacupuncture for TN

If you are considering acupuncture, this acupuncture and trigeminal neuralgia study supports a sensible set of questions:

Will you use manual acupuncture or electroacupuncture?
How many sessions will I receive, and over what time?
What training, regulation, and clinical governance do you work under?
How will you measure outcomes (pain, triggers, daily function)?
What is the plan if symptoms worsen or if numbness develops?
How will this fit alongside medication and specialist review?

Those questions protect patients from vague promises. They also protect good practitioners from unrealistic expectations.

Acupuncture and trigeminal neuralgia study: what it does not prove

It is just as important to say what the evidence does not prove.

This study does not prove that:

Electroacupuncture will work for everyone
Electroacupuncture is better than all other options
The same results will appear in UK services
People can safely stop medication without clinical advice

It also does not answer every long-term question. For example, recurrence patterns matter in trigeminal neuralgia. People deserve clear follow-up over years, not only months.

Safety and standards

Acupuncture is often described as “low risk”. That can be true in the right hands. However, “low risk” is not the same as “no risk”.

People with trigeminal neuralgia can be highly sensitive to touch and stimulation. Some also have complex neurological histories or medication vulnerability; because of that, professional standards, infection control, and clear escalation routes matter.

If you try any complementary approach, keep your GP and specialist informed. Also, do not let a new option delay urgent help if pain, mood, or crisis risk escalates.

A note from me

“People living with trigeminal neuralgia deserve evidence-led hope, not marketing. This study is worth attention, but the standard must stay the same: clear methods, transparent outcomes, and honest limits.”
Aneeta Prem MBE

What happens next

The next step is not louder headlines. It is better evidence.

We need replication, longer follow-up, clearer subgroup analysis, and practical reporting that clinicians can apply safely. We also need a UK-facing discussion about access to accredited, regulated care without pressure into unproven claims.

If you are a researcher or clinician planning work in this area, please design studies that reflect real life: mixed symptoms, medication burden, and the daily reality of triggers and fear.

References

Journal of Neurology (open access full paper):
https://link.springer.com/article/10.1007/s00415-024-12433-x

PubMed abstract record:
https://pubmed.ncbi.nlm.nih.gov/38816482/

NHS trigeminal neuralgia treatment page:
https://www.nhs.uk/conditions/trigeminal-neuralgia/treatment/

Royal College of Surgeons trigeminal neuralgia guidelines (PDF):
https://www.rcseng.ac.uk/-/media/files/rcs/fds/guidelines/trigemina-neuralgia-guidelines_2021_v4.pdf